XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
30.02
-0.08 (-0.27%)
Nov 20, 2024, 4:00 PM EST - Market open
XOMA Royalty Employees
XOMA Royalty had 13 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,662,000
Profits / Employee
-$2,725,692
Market Cap
353.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enhabit | 10,800 |
ZimVie | 2,600 |
Ginkgo Bioworks Holdings | 1,218 |
Valneva SE | 676 |
Kamada | 378 |
Alector | 244 |
AVITA Medical | 207 |
Omeros | 198 |
XOMA News
- 14 days ago - XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - GlobeNewsWire
- 4 weeks ago - Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - Business Wire
- 4 weeks ago - XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - GlobeNewsWire
- 5 weeks ago - XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties - Seeking Alpha
- 5 weeks ago - I Am Banking On The Silver Tsunami With Big Dividends - Seeking Alpha
- 6 weeks ago - XOMA Stock Dips Amidst Biotech Sector Decline - GuruFocus
- 2 months ago - Zevra's MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC) - GlobeNewsWire
- 2 months ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire